Avalo Therapeutics, Inc. AVTX

15.47 (0.25) (1.59%) as of 25 Sep

Follow AVTX

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	20.97%	(72.43%)	(88.76%)	(36.27%)
ROA Full definition →		10.56%	(58.58%)	(71.09%)	(32.50%)
ROIC Full definition →		0.00%	0.00%	0.00%	(118.21%)
Return on Tangible Assets Full definition →		11.09%	(84.33%)	(109.20%)	(25.92%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(3.73)	(3.84)	(2.97)	(1.57)
Free Cash Flow Full definition →		(52.26)	(51.46)	(59.69)	(68.29)
Other line items
Cash ROIC Full definition →		(25.71%)	(28.36%)	(39.67%)	(8.04%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		(4.43)	0.66	0.70	0.68
Depreciation/Fixed assets Full definition →		0.73	0.75	0.60	0.38
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(3.73)	(3.84)	(2.97)	(1.57)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Net Profit Margin Full definition →		0.00%	0.00%	0.00%	0.00%

Columns are period end dates

Powerpack